DrugPatentWatch Database Preview
Eugia Pharma Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for EUGIA PHARMA, and what generic and branded alternatives to EUGIA PHARMA drugs are available?
EUGIA PHARMA has nine approved drugs.
Summary for Eugia Pharma
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 9 |
| Patent Litigation for Eugia Pharma: | See patent lawsuits for Eugia Pharma |
Drugs and US Patents for Eugia Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | HYDROXYPROGESTERONE CAPROATE | hydroxyprogesterone caproate | SOLUTION;INTRAMUSCULAR | 211142-001 | May 9, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| Eugia Pharma | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 205529-002 | Sep 6, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Eugia Pharma | CAPECITABINE | capecitabine | TABLET;ORAL | 210604-001 | Apr 17, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Eugia Pharma | CAPECITABINE | capecitabine | TABLET;ORAL | 210604-002 | Apr 17, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
